Back to search

Sweden· SE-20041118000029

Doloproct 1 mg/40 mg Suppositorium

A medicinal product containing fluocortolone pivalate + anhydrous lidocaine hydrochloride, registered in Sweden by Karo Pharma AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedDoloproct 1 mg/40 mg SuppositoriumATC—REGISTER NO.SE-20041118000029PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Fluocortolone Pivalate + Anhydrous Lidocaine Hydrochloride
Manufacturer
Karo Pharma AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20041118000029

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluocortolone pivalate + anhydrous lidocaine hydrochloride in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluocortolone pivalate + anhydrous lidocaine hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Doloproct
  • Bulgaria · Долопрокт
  • Germany · Doloproct
  • Denmark · Doloproct
  • Estonia · Doloproct
  • Finland · Neoproct, Neoproct Kombinationsförpackning
  • Greece · Doloproct
  • Hungary · Doloproct
  • Iceland · Doloproct
  • Lithuania · Doloproct
  • Latvia · Doloproct
  • Portugal · Ultraproct
  • Slovakia · Doloproct

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6813dabb-3dc2-414a-85bd-df81f96bc8b4
GET /v1/drugs/6813dabb-3dc2-414a-85bd-df81f96bc8b4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC"
  ],
  "se_npl_id": "20041118000029",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20041118000029",
  "product_doc_link": "https://docetp.mpa.se/LMF/Doloproct%20suppository%20SmPC_09001bee807a2189.pdf"
}

See everything about fluocortolone pivalate + anhydrous lidocaine hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.